Evidence for host-cell selection of influenza virus antigenic variants.

PubWeight™: 4.24‹?› | Rank: Top 1%

🔗 View Article (PMID 6190093)

Published in Nature on July 29, 1983

Authors

G C Schild, J S Oxford, J C de Jong, R G Webster

Articles citing this

Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol (1990) 3.60

Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus. J Virol (1984) 3.11

Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses. J Clin Microbiol (1986) 3.04

Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J Virol (1986) 2.52

Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol (1990) 2.45

Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 2.42

Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res (1983) 2.41

Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J Virol (1994) 2.40

The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci U S A (2002) 2.39

1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. Emerg Infect Dis (2003) 2.32

Hemagglutinin of swine influenza virus: a single amino acid change pleiotropically affects viral antigenicity and replication. Proc Natl Acad Sci U S A (1983) 2.28

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J Virol (1996) 2.26

Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol (1988) 2.22

Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98

Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes. J Virol (1996) 1.88

Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. J Virol (1990) 1.84

Hemagglutinin mutations related to antigenic variation in H1 swine influenza viruses. J Virol (1992) 1.66

MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J Clin Microbiol (2008) 1.59

Deep Sequencing for Evaluation of Genetic Stability of Influenza A/California/07/2009 (H1N1) Vaccine Viruses. PLoS One (2015) 1.41

African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J Virol (1996) 1.39

Distinct glycoprotein inhibitors of influenza A virus in different animal sera. J Virol (1991) 1.33

Characterization of a porcine lung epithelial cell line suitable for influenza virus studies. J Virol (2001) 1.33

Single amino acid substitutions in the hemagglutinin can alter the host range and receptor binding properties of H1 strains of influenza A virus. J Virol (1991) 1.32

A new concept of the epidemic process of influenza A virus. Epidemiol Infect (1987) 1.29

Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics. J Virol (2004) 1.28

Crystal structure of unliganded influenza B virus hemagglutinin. J Virol (2008) 1.24

Mink lung epithelial cells: unique cell line that supports influenza A and B virus replication. J Clin Microbiol (1998) 1.22

Traditional and new influenza vaccines. Clin Microbiol Rev (2013) 1.22

Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J Virol (1995) 1.21

Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A. Proc Natl Acad Sci U S A (1985) 1.19

Influenza A virus lacking M2 protein as a live attenuated vaccine. J Virol (2009) 1.16

Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK). Bull World Health Organ (1987) 1.13

A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA. J Virol (2002) 1.12

Structural basis for receptor specificity of influenza B virus hemagglutinin. Proc Natl Acad Sci U S A (2007) 1.10

Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J Virol (2011) 1.09

Development of high-yield influenza A virus vaccine viruses. Nat Commun (2015) 1.08

Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology (1990) 1.08

Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein. J Virol (1995) 1.07

The threat of avian influenza A (H5N1). Part IV: Development of vaccines. Med Microbiol Immunol (2007) 1.06

A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models. Influenza Other Respir Viruses (2009) 1.01

Antigenic heterogeneity within influenza A (H3N2) virus strains. Bull World Health Organ (1988) 0.99

Influenza A and B virus intertypic reassortment through compatible viral packaging signals. J Virol (2014) 0.97

New aspects of influenza viruses. Clin Microbiol Rev (1992) 0.97

Sequence of an influenza virus hemagglutinin determined directly from a clinical sample. Proc Natl Acad Sci U S A (1990) 0.96

Host cell-mediated selection of influenza A (H3N2) virus variant subpopulations: lack of association between antigenic and receptor-binding properties. Epidemiol Infect (1988) 0.95

What is the true nature of epidemic influenza virus and how do new epidemic viruses spread? Epidemiol Infect (1987) 0.93

Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target. Expert Rev Mol Med (2010) 0.93

In vivo selection of respiratory syncytial viruses resistant to palivizumab. J Virol (2005) 0.89

Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. PLoS One (2011) 0.87

Diversifying selective pressure on influenza B virus hemagglutinin. J Med Virol (2009) 0.87

Antigenic and amino acid sequence analysis of the variants of H1N1 influenza virus in 1986. Bull World Health Organ (1987) 0.85

Production of a novel influenza vaccine using insect cells: protection against drifted strains. Influenza Other Respir Viruses (2007) 0.85

Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses. Hum Vaccin (2010) 0.85

Avian influenza: mixed infections and missing viruses. Viruses (2013) 0.84

Developing vaccines to combat pandemic influenza. Viruses (2010) 0.84

Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans. J Virol (2016) 0.84

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model. PLoS One (2011) 0.83

Antigenic and genetic analyses of influenza type B viruses isolated in Russia, 1987-91. Epidemiol Infect (1993) 0.83

Antigenic heterogeneity among influenza A(H3N2) field isolates during an outbreak in 1982/83, estimated by methods of numerical taxonomy. J Hyg (Lond) (1985) 0.82

Low seroprevalent species D adenovirus vectors as influenza vaccines. PLoS One (2013) 0.81

The haemagglutinins of influenza A (H1N1) viruses in the 'O' or 'D' phases exhibit biological and antigenic differences. Epidemiol Infect (1993) 0.80

Challenges in antigenic characterization of circulating influenza A(H3N2) viruses during the 2011-2012 influenza season: an ongoing problem? J Clin Microbiol (2015) 0.79

Optimization of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses. Influenza Other Respir Viruses (2015) 0.78

Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses. J Gen Virol (2016) 0.77

Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors. Med Microbiol Immunol (2005) 0.77

Biochemical techniques for the genetic and phenotypic analysis of viruses: 'molecular epidemiology'. J Hyg (Lond) (1985) 0.76

Bringing influenza vaccines into the 21st century. Hum Vaccin Immunother (2013) 0.76

The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus. Virology (2013) 0.76

Morphology and antigenicity studies on reassortant influenza (H3N2) viruses for use in inactivated vaccines. J Hyg (Lond) (1985) 0.75

Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones. Vaccine (2016) 0.75

Infectivity of equine H3N8 influenza virus in bovine cells and calves. Influenza Other Respir Viruses (2010) 0.75

Egg-grown and tissue-culture-grown variants of influenza A (H3N2) virus with special attention to their use as antigens in seroepidemiology. Epidemiol Infect (1987) 0.75

Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial. Yonsei Med J (2016) 0.75

Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses. Can J Vet Res (1993) 0.75

Articles by these authors

Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol (2001) 21.17

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature (2004) 16.76

A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med (2001) 16.32

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet (1998) 16.30

To What Degree Are Mortality Statistics Dependable? Am J Public Health Nations Health (1940) 15.65

A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16

Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70

Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol (1989) 10.63

Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature (2005) 10.04

Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A (2006) 9.26

Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med (1966) 9.26

A pandemic warning? Nature (1997) 8.70

Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci U S A (1999) 8.62

Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol (1998) 8.44

Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06

Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology (1998) 7.99

Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol (1999) 7.72

Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology (1978) 7.35

Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A (2005) 7.12

H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A (2004) 6.61

Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J Virol (2001) 6.45

Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. J Immunol (1967) 6.41

Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci U S A (2002) 6.17

Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01

The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87

Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol (2005) 5.78

Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol (1968) 5.69

Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54

Evolution of swine H3N2 influenza viruses in the United States. J Virol (2000) 5.48

The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25

H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol (2000) 5.17

Replication of avian influenza viruses in humans. Arch Virol (1991) 5.10

Assembly of influenza hemagglutinin trimers and its role in intracellular transport. J Cell Biol (1986) 4.93

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res (2002) 4.85

Determinants of immunity to influenza infection in man. Br Med Bull (1979) 4.62

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A (1993) 4.49

Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A (2006) 4.49

H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology (2001) 4.46

The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine. Virology (1978) 4.43

Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci U S A (1988) 4.41

Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology (1993) 4.40

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA (2001) 4.38

Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology (2000) 4.37

Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell (1987) 4.34

Potential for transmission of avian influenza viruses to pigs. J Gen Virol (1994) 4.24

Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17

Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology (1984) 4.15

The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl. Can J Microbiol (1980) 4.14

The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06

Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology (1996) 4.04

Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis (1996) 4.04

Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses. J Virol (1991) 4.01

Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98

Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature (1979) 3.91

Is the gene pool of influenza viruses in shorebirds and gulls different from that in wild ducks? Virology (1988) 3.90

Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ (1975) 3.88

The polypeptide composition of influenza A viruses. Virology (1971) 3.79

Characterization of an influenza A virus from seals. Virology (1981) 3.75

Studies on the origin of pandemic influenza. 3. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza. Virology (1973) 3.75

Replication of avian influenza A viruses in mammals. Infect Immun (1981) 3.69

A quantitative, single-radial-diffusion test for immunological studies with influenza virus. J Gen Virol (1972) 3.69

Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64

Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology (2006) 3.59

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet (2004) 3.54

Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology (1993) 3.54

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis (1998) 3.47

Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. J Virol (1990) 3.40

Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool. J Med Virol (1983) 3.39

Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J Virol (1992) 3.37

Disquisitions on Original Antigenic Sin. II. Proof in lower creatures. J Exp Med (1966) 3.36

Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1? J Virol (2000) 3.35

Epitopes on protein antigens: misconceptions and realities. Cell (1990) 3.32

Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J Virol (1991) 3.29

Conjunctivitis in human beings caused by influenza A virus of seals. N Engl J Med (1981) 3.27

Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature (1987) 3.26

Virulence of avian influenza A viruses for squirrel monkeys. Infect Immun (1982) 3.22

A common surface antigen in influenza viruses from human and avian sources. J Gen Virol (1968) 3.20

Rapid evolution of H5N1 influenza viruses in chickens in Hong Kong. J Virol (1999) 3.20

Isolation and characterization of influenza A viruses from avian species in Hong Kong. Bull World Health Organ (1977) 3.17

Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology (1980) 3.15

Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol (2003) 3.15

The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005. J Virol (2007) 3.12

Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion. J Gen Virol (1969) 3.11

Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus. J Virol (1984) 3.11

Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10

The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03

Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med (1978) 2.99

Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. Virology (1995) 2.99

Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89

Immunity to influenza in ferrets. I. Response to live and killed virus. Br J Exp Pathol (1972) 2.78

Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology (1982) 2.78

Molecular evolution of H6 influenza viruses from poultry in Southeastern China: prevalence of H6N1 influenza viruses possessing seven A/Hong Kong/156/97 (H5N1)-like genes in poultry. J Virol (2002) 2.76

Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus. Virology (1990) 2.75

Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol (1985) 2.75

Continuing evolution of H9N2 influenza viruses in Southeastern China. J Virol (2004) 2.75

Persistence of Hong Kong influenza virus variants in pigs. Science (1977) 2.72

Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71